Xiao, G.; Gao, S.; Xie, Y.; Wang, Z.; Shu, M.
Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis. Medicina 2024, 60, 1646.
https://doi.org/10.3390/medicina60101646
AMA Style
Xiao G, Gao S, Xie Y, Wang Z, Shu M.
Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis. Medicina. 2024; 60(10):1646.
https://doi.org/10.3390/medicina60101646
Chicago/Turabian Style
Xiao, Guoguang, Shan Gao, Yongmei Xie, Zhiling Wang, and Min Shu.
2024. "Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis" Medicina 60, no. 10: 1646.
https://doi.org/10.3390/medicina60101646
APA Style
Xiao, G., Gao, S., Xie, Y., Wang, Z., & Shu, M.
(2024). Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis. Medicina, 60(10), 1646.
https://doi.org/10.3390/medicina60101646